Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
May 29, 2012
Patent Application Number
12494965
Date Filed
June 30, 2009
Patent Citations Received
Patent Primary Examiner
Patent abstract
Monoclonal antibodies that bind and inhibit activation of fibroblast growth factor receptor 3 (FGFR3) are disclosed. The antibodies can be used to treat cell proliferative diseases and disorders, including certain forms of cancer, associated with activation of FGFR3.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
